SAN ANTONIO--()--Kinetic Concepts, Inc. announced today that Peter Arnold has been named Senior Vice President of Innovation and Strategic Marketing.
As Senior Vice President of Innovation and Strategic Marketing, Arnold will be responsible for setting the global product strategy for KCI. He will have responsibility for providing strategic leadership in the design and development aspects of research, science and technology across the full spectrum of KCI products.
Arnold has extensive leadership experience in both public and private sector management. He most recently established Newcastle Science City, an innovation incubator and 19 acre science development in the UK which used a new approach to innovation to create many new businesses in the region. Previously, Arnold worked at Smith & Nephew as the Group Director of Technology. In this capacity he was responsible for group-wide technology, research and development portfolio, new product stream, innovation and medical & regulatory risk. He was also the Worldwide Director of Wound Management Development at Johnson & Johnson.
“Peter’s experience in medical device research and development and acquisition licensing makes him a great fit at KCI as we think bigger and more strategic,” said Joe Woody, president & CEO, KCI. “With a focus on the innovation process and global product strategy, Peter will help define our platforms for the future of negative pressure technologies and adjacencies with new approaches in open and virtual innovation.”
About KCI
Kinetic Concepts, Inc. is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI has significantly advanced the science of wound healing over the course of more than three decades. KCI's success can be traced to a history deeply rooted in innovation and a passion for significantly improving patient outcomes while reducing the overall cost of care for patients around the world. KCI's proprietary negative pressure technologies have revolutionized the way in which caregivers treat a wide variety of wound types. The V.A.C.® Therapy System has been used on more than 6 million wounds worldwide. Additional information about KCI and its products is available at www.KCI1.com.